Five things for pharma marketers to know: Thursday, June 30, 2016



1. Boehringer Ingelheim is eliminating 725 jobs in the U.S. The cuts are part of a broad reorganization. (Endpoints)

2. Bill Gates supports the current U.S. drug pricing system. “The drug companies are turning out miracles, and we need their R&D budgets to stay strong. They need to see the opportunity,” he said. (Bloomberg)

3. Merck announced a partnership with Moderna Therapeutics for personalized cancer vaccines. The deal includes a $200 million upfront payment. (Philadelphia Business Journal)

4. The “Brexit” vote is likely to hurt Britain's National Health Service — and could raise drug costs. The decline in value of the British pound could increase costs for the NHS. (WSJ)

5. ICYMI: As large hospital systems crackdown on industry-sponsored meals, drugmakers are increasingly targeting smaller hospitals. (Boston Globe)